跳至主要内容
临床试验/KCT0001508
KCT0001508已完成未知

The effect ot topical recombinant human epidermal growth factor and moisturizers which contain skin identical lipids on xerosis: a randomized, double blinded controlled clinical trial

Samsung Medical Center0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 70(Year)(—)
性别
All

入选标准

  • 1.All patients were between the ages of 20 and 70 (male or female)
  • 2.All patients had a diagnosis of xerosis as defined by the xerosis severity scale (XSS) presented by Rogers et al and scores of at least 3 on both shins.
  • 3.All of the included patients signed written informed consent for their participation.

排除标准

  • Patients were excluded if there was known or suspected sensitivity to test ingredients, current history of any dermatologic diseases requiring treatment (such as psoriasis, atopic dermatitis and eczema), a condition that could interfere with the study’s conduct, use of oral/topical corticosteroids or immunosuppressants, or light therapy within 4 weeks prior to the study.

研究者

相似试验